Brought to you by the International Journal of Pharmaceutical Compounding FREE TRIAL    FORMULATIONS    MY ACCOUNT 
Compounding This Week Newsletter from www.CompoundingToday.com
Our Compounding Knowledge, Your Peace of Mind
July 15, 2016  |  Volume 13  |  Issue 28
IN THIS ISSUE
 
SUBSCRIPTIONS / INFO
 
CLASSIFIEDS
 
ABOUT COMPOUNDINGTODAY
 
FREE RESOURCES
 
SUBSCRIBER RESOURCES
Cappucine from BiosRX
Receive a free compounding CD with new subscription to IJPC.
PeridoxRTU Sporicidal Disinfectant for Hazardous Drug Decontamination & Disinfection - www.contechealthcare.com
 
Loyd V. Allen, Jr., Ph.d., R.Ph Letter from the Editor
Implementing United States Pharmacopeia <800>, Part 22: Hazardous Drugs-Handling in Healthcare Settings
 

(Learning about USP Chapter <800> in 10 minutes a week.)

18. MEDICAL SURVEILLANCE
Personnel handling HDs regularly SHOULD be enrolled in a medical surveillance program (MSP).

The MSP includes:

  • Assessment and documentation of symptom complaints
  • Physical findings and
  • Laboratory values

Tracking these individuals over time allows comparison of health variables which may facilitate early detection of a:

  • Change in a laboratory value or
  • Change in a health condition

The individual's data can be:

  • Compared over time
  • Compared with others with the HD exposure group and
  • Compared with those with no exposure

Elements of the MSP SHOULD include:

  • Organized identification of workers potentially exposed to HDs due to their job
  • Use of an entity-based or contracted employee health service to perform the MSP
  • Initial baseline assessment to include
    • Medical (including reproductive) history
    • Work history
    • Physical examination and
    • Laboratory testing
  • Methods used to assess exposure history include a review of:
    • Records of HDs handled, quantities and dosage forms
    • Estimated number of HDs handled per week
    • Estimates of hours spent handling HDs per week and/or per month
    • Performance of a physical assessment and laboratory studies linked to target organs of commonly used HDs
  • Maintain MSP records according to OSHA regulations
  • Prospective monitoring of workers' health
  • Data monitoring to identify prevention failures leading to health effects
  • Follow-up plan development for workers showing health changes
  • Exit examination when a worker ceases to work at the facility

Next week, we will look at Section 18.1 Follow-Up Plan.

QUESTIONS

Questions received on the Medical Surveillance Program section.

  1. In a medical surveillance program, what can a PIC do if the employee does not want the employer to see their medical records?
  2. In a medical surveillance program, what "health variables" should be followed over time for individual workers? (How detailed?)
  3. In a medical surveillance program, who pays for all the tests, etc.?
  4. In a medical surveillance program paid for by the employer, does the employer have access to and/or own the data?
  5. In a medical surveillance program, how does an employer obtain data from the "unexposed workers" for comparison to the "exposed workers"?
  6. What are the limitations on "potentially exposed" to HDs?

NOTE: USP responses to these questions are nearing completion and will soon be posted on the USP website. We will announce this as soon as it happens. For a complete list of questions asked so far, please go to: http://www.ijpc.com/USP800Questions


Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition

 

Announcements

FDA 503A inspections procedures to change. See the following:

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory
Information/PharmacyCompounding/UCM510684.pdf

USP <800> Standard Operating Procedures

www.CompoundingToday.com now has over 600 standard operating procedures; 54 are new and specific for compounding with hazardous drugs.

 

IJPC Now on Facebook and Youtube

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information - http://www.facebook.com/IJPCompounding

Learn about the Journal's new multi-media features and view our growing collection of educational and training videos at www.ijpc.com/video or by subscribing to our Youtube channel at https://www.youtube.com/user/IJPCompounding.

 

Did You Know ...

�that a recent study suggests that caffeine absorption and exposure from coffee and energy drinks are similar irrespective of beverage temperature or rate of consumption. (Clin Tox 554; 4: 308-312)?

 

Tip of the Week

One must keep in mind if asked questions about energy drinks that they often contain other stimulants in addition to caffeine.

 

Looking Back

Ed's face,
Is rough and rugged!
Ed's wife,
Doesn't hug Ed!
     Burma Shave

Copyright 2016
International Journal of Pharmaceutical Compounding, Inc.
122 N Bryant Ave, Edmond OK 73034
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
info@compoundingtoday.com
Reprints & Permissions: Reprints@ijpc.com